Medicare Enrolled
Dr. Jose Alemar, MD
Hematology · Clearwater, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alemar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alemar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alemar
Dr. Jose Alemar is a hematology in Clearwater, FL, with 20 years in practice. Based on federal Medicare data, Dr. Alemar performed 6,819 Medicare services across 1,311 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alemar received a total of $9,452 from 72 pharmaceutical and/or device companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alemar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ 6,819 Medicare services$ $9,452 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,819
Medicare services
Bottom 27% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,311
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~341 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Monoferric) | 1,600 | $16 | $74 |
| Epoetin alfa injection (Procrit) for anemia | 1,300 | $5 | $24 |
| Dexamethasone injection (steroid) | 762 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $39 |
| Complete blood count (CBC) with differential | 418 | $8 | $29 |
| Blood draw (venipuncture) | 414 | $8 | $9 |
| Office visit, established patient (30-39 min) | 245 | $100 | $390 |
| Comprehensive metabolic blood panel | 213 | $10 | $39 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 151 | $22 | $100 |
| Drug injection, under skin or into muscle | 132 | $10 | $67 |
| Administration of chemotherapy into vein, 1 hour or less | 109 | $95 | $412 |
| Office visit, established patient (20-29 min) | 95 | $70 | $277 |
| Immunoglobulin level test | 84 | $9 | $28 |
| Nephelometry, test method using light | 66 | $13 | $41 |
| Ferritin level test (iron stores) | 60 | $13 | $41 |
| Iron level test | 59 | $6 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 59 | $44 | $203 |
| Injection, diphenhydramine hcl, up to 50 mg | 58 | $1 | $4 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 58 | $70 | $210 |
| Iron binding capacity test | 56 | $9 | $27 |
| Office visit, established patient, complex (40-54 min) | 51 | $140 | $550 |
| Administration of chemotherapy into vein, each additional hour | 46 | $22 | $149 |
| Injection of additional new drug or substance into vein | 42 | $11 | $64 |
| Administration of additional new drug or substance into vein, 1 hour or less | 35 | $49 | $203 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 28 | $1 | $6 |
| Vitamin B-12 level test | 27 | $15 | $46 |
| New patient office visit, complex (60-74 min) | 27 | $166 | $673 |
| Immunologic analysis technique on serum (immunofixation) | 26 | $22 | $68 |
| New patient office visit (45-59 min) | 26 | $131 | $509 |
| Protein measurement, serum | 25 | $11 | $34 |
| Lactate dehydrogenase (enzyme) level | 22 | $6 | $19 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 21 | $3 | $12 |
| Carcinoembryonic antigen (cea) protein level | 18 | $19 | $70 |
| Thyroid stimulating hormone (TSH) test | 16 | $16 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.5% high complexity
43.5% medium
29.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,452
Total received (2018-2024)
Avg $1,350/year across 7 years
Top 44% in FL for hematology
72
Companies
350
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,933 (83.9%)
Other
Charitable contributions, space rental, and other categories
$1,310 (13.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$209 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,101
2023$2,138
2022$706
2021$192
2020$106
2019$642
2018$567
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,756
PFIZER INC.
$564
Janssen Biotech, Inc.
$492
GENZYME CORPORATION
$412
Karyopharm Therapeutics Inc.
$336
Celgene Corporation
$307
Gilead Sciences, Inc.
$277
Daiichi Sankyo Inc.
$276
Blueprint Medicines Corporation
$275
AstraZeneca Pharmaceuticals LP
$247
Kite Pharma, Inc.
$240
Rigel Pharmaceuticals, Inc.
$224
E.R. Squibb & Sons, L.L.C.
$221
Seagen Inc.
$217
Genentech USA, Inc.
$205
GlaxoSmithKline, LLC.
$164
SOBI, INC
$150
AbbVie Inc.
$148
Astellas Pharma US Inc
$142
Adaptive Biotechnologies Corporation
$136
Exelixis Inc.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$127
EMD Serono, Inc.
$122
SERVIER PHARMACEUTICALS LLC
$119
Myriad Genetic Laboratories, Inc.
$112
Incyte Corporation
$109
Ipsen Biopharmaceuticals, Inc
$106
Merck Sharp & Dohme Corporation
$105
Amgen Inc.
$101
ABBVIE INC.
$98
ARRAY BIOPHARMA INC
$90
Merck Sharp & Dohme LLC
$83
Eisai Inc.
$80
Lilly USA, LLC
$78
CTI BioPharma Corp.
$76
Stryker Corporation
$74
TerSera Therapeutics LLC
$70
Azurity Pharmaceuticals, Inc.
$64
ImmunoGen, Inc.
$50
TAIHO ONCOLOGY, INC.
$48
Acrotech Biopharma Inc.
$47
Janssen Pharmaceuticals, Inc
$46
Mirati Therapeutics, Inc.
$45
Pharmacyclics LLC, an AbbVie Company
$45
Sumitomo Pharma America, Inc.
$44
Pharmacosmos Therapeutics Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
ADC Therapeutics America, Inc.
$34
PharmaEssentia USA Corporation
$31
Stemline Therapeutics Inc.
$30
Genmab U.S., Inc.
$30
Amneal Pharmaceuticals LLC
$30
SpringWorks Therapeutics, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Deciphera Pharmaceuticals Inc.
$26
Fennec Pharmaceuticals, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$25
Seattle Genetics, Inc.
$23
Dendreon Pharmaceuticals LLC
$22
BeiGene USA, Inc.
$21
Kyowa Kirin, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$20
CSL Behring
$18
Alnylam Pharmaceuticals Inc.
$18
Apellis Pharmaceuticals, Inc.
$17
AbbVie, Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$14
Teva Pharmaceuticals USA, Inc.
$12
Acrotech Biopharma LLC
$12
SECURA BIO, INC.
$11
Dova Pharmaceuticals
$11
Veracyte, Inc.
$1
Top 3 companies account for 29.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AVASTIN · AYVAKIT · Afstyla · Alecensa · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINQAIR · COPIKTRA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FRUZAQLA · Fabhalta · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JADENU · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · MYRISK · NERLYNX · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OPTABLATE · ORGOVYX · Onivyde · Orserdu · PADCEV · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · RYZNEUTA · Revlimid · Rezlidhia · SARCLISA · SUTENT · Somatuline Depot · Stivarga · TECVAYLI · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xolair · Xtandi · Yescarta · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $139 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
41
Per 100K population
4.3
County median income
$70,293
Nearest hospital
MEASE COUNTRYSIDE HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Alemar is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Alemar experienced with iron infusion (monoferric)?
Based on Medicare claims data, Dr. Alemar performed 1,600 iron infusion (monoferric) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alemar receive payments from pharmaceutical companies?
Yes. Dr. Alemar received a total of $9,452 from 72 companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alemar's costs compare to other hematologys in Clearwater?
Dr. Alemar's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alemar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Clearwater
Browse hematologys in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology